Parnax Lab

Parnax Lab Accounts Payable

The Accounts Payable of Parnax Lab (506128.BO) as of Nov 4, 2026 is 286.43 M INR. In the previous year, Accounts Payable was 318.02 M INR — a change of -9.93% (lower).

Accounts Payable

286.43 MINR

YoY

-9.93%

Last updated:

Accounts Payable of Parnax Lab is 2025 286.43 M INR. Accounts Payable of Parnax Lab was 2024 318.02 M INR. It decreases by -9.93% lower compared to the previous year.

The Parnax Lab Accounts Payable history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Accounts Payable
Date
Accounts Payable
Jan 1, 2018
76.76 M INR
Jan 1, 2019
72.58 M INR
Jan 1, 2020
108.41 M INR
Jan 1, 2021
62.32 M INR
Jan 1, 2022
220.78 M INR
Jan 1, 2023
222.38 M INR
Jan 1, 2024
318.02 M INR
Jan 1, 2025
286.43 M INR
The Parnax Lab Accounts Payable history
YEARAccounts PayableYoY
286.43 MINR-9.93%
318.02 MINR+43.00%
222.38 MINR+0.73%
220.78 MINR+254.28%
62.32 MINR-42.52%
108.41 MINR+49.36%
72.58 MINR-5.44%
76.76 MINR+0.08%
76.70 MINR+148.36%
30.88 MINR-66.69%
92.71 MINR-58.60%
223.92 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Parnax Lab Stock analysis

What does Parnax Lab do? Parnax Lab Ltd. generates revenue through manufacturing and exporting pharmaceutical formulations, including cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, geriatric special formulations, highly viscous products, and suspensions. The company trades pharmaceuticals and medicinal products, focusing on high-volume oral formulations for diverse consumer segments. Naxpar Pharma Private Limited serves as its subsidiary in these operations. The firm's primary customers are likely healthcare providers, pharmacies, and distributors within the pharmaceutical industry, though specific buyer details are not disclosed. Parnax Lab Ltd. operates through the pharmaceutical formulations segment, emphasizing export-driven manufacturing and trading activities. Its product portfolio targets various health needs, from pediatric to geriatric care, with a strong focus on oral delivery systems. Parnax Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parnax Lab stock

Accounts Payable of Parnax Lab is 286.43 M INR in 2025.

Accounts Payable of Parnax Lab changed from 318.02 M INR to 286.43 M INR, representing a -9.93% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Accounts Payable Parnax Lab since 2006 – with annual values, charts, and detailed analysis.

Accounts payable represents money owed to suppliers for goods and services received. It is a key component of working capital management.

Accounts Payable's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Payable's Parnax Lab historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Parnax Lab

All Key Metrics — Parnax Lab